AU2023206823A1 - Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof - Google Patents

Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof Download PDF

Info

Publication number
AU2023206823A1
AU2023206823A1 AU2023206823A AU2023206823A AU2023206823A1 AU 2023206823 A1 AU2023206823 A1 AU 2023206823A1 AU 2023206823 A AU2023206823 A AU 2023206823A AU 2023206823 A AU2023206823 A AU 2023206823A AU 2023206823 A1 AU2023206823 A1 AU 2023206823A1
Authority
AU
Australia
Prior art keywords
ppm
azabicyclo
methoxypiperidin
fluoropyrimidin
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023206823A
Other languages
English (en)
Inventor
Taro ASABA
Takashi Fukuyama
Yoko Ito
Ikuo Kushida
Nobuaki Sato
So Yasui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of AU2023206823A1 publication Critical patent/AU2023206823A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU2023206823A 2022-01-14 2023-01-12 Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof Pending AU2023206823A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-004608 2022-01-14
JP2022004608 2022-01-14
PCT/JP2023/000561 WO2023136279A1 (ja) 2022-01-14 2023-01-12 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶

Publications (1)

Publication Number Publication Date
AU2023206823A1 true AU2023206823A1 (en) 2024-07-11

Family

ID=87279104

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023206823A Pending AU2023206823A1 (en) 2022-01-14 2023-01-12 Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof

Country Status (10)

Country Link
US (1) US20250051322A1 (https=)
EP (1) EP4438602A4 (https=)
JP (1) JPWO2023136279A1 (https=)
KR (1) KR20240134870A (https=)
CN (1) CN118451076A (https=)
AU (1) AU2023206823A1 (https=)
CA (1) CA3243267A1 (https=)
MX (1) MX2024008024A (https=)
TW (1) TW202334120A (https=)
WO (1) WO2023136279A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
EP3896060B1 (en) * 2018-12-12 2023-08-16 Takeda Pharmaceutical Company Limited Heterocyclic compound
TWI888599B (zh) * 2020-07-17 2025-07-01 日商衛材R&D企管股份有限公司 取代哌啶化合物及其用途

Also Published As

Publication number Publication date
CN118451076A (zh) 2024-08-06
EP4438602A1 (en) 2024-10-02
TW202334120A (zh) 2023-09-01
CA3243267A1 (en) 2025-04-10
US20250051322A1 (en) 2025-02-13
KR20240134870A (ko) 2024-09-10
WO2023136279A1 (ja) 2023-07-20
MX2024008024A (es) 2024-07-15
JPWO2023136279A1 (https=) 2023-07-20
EP4438602A4 (en) 2025-11-19

Similar Documents

Publication Publication Date Title
US11479552B2 (en) Substituted piperidine compounds and their use
BG65966B1 (bg) Производни на триазолил тропан като модулатори на ссr5 рецептори
AU2023206823A1 (en) Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystals thereof
JP3701964B1 (ja) キヌクリジン誘導体の新規な塩
RU2840772C1 (ru) Замещенные пиперидиновые соединения и их применение
JP7591592B2 (ja) 置換ピペリジン化合物を含有する医薬
TWI922338B (zh) 取代哌啶化合物及其用途
EA045865B1 (ru) Замещенные пиперидиновые соединения и их применение
US20250230148A1 (en) Crystal of fused tricyclic derivative or pharmaceutically acceptable salt thereof
JP4614084B2 (ja) キヌクリジン誘導体含有医薬組成物
WO2025185704A1 (zh) 一种kif18a抑制剂的晶型及其制备方法和应用
HK40083601A (en) Substituted piperidine compound and application thereof
HK40059280B (zh) 可用作RORγ调节剂的苯胺类化合物
CN101175751B (zh) 具有哌啶环的吲哚衍生物的晶体和其制备方法
HK40083601B (zh) 取代的哌啶化合物及其用途